国内吸金超30亿美元!MNC押注TCE疗法

动脉vcbeat
08 Dec 2024

随着MNC与国内Biotech的BD交易不断涌现,TCE疗法浮出水面,成为医药行业重点押注的赛道。10月31日,艾伯维出手14.65亿美元,押注TCE,与EvolveImmune Therapeutics达成合作,利用其专有的TCE平台共同开发肿瘤药物。10月29日,GSK宣布和恩沐生物达成协议,将以 3 亿美元的预付款收购恩沐生物处于临床阶段的靶向 CD19 和 CD20 的双重 T 细胞接合器...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10